|
Background
All medicines and medical devices must receive a licence (or conditional exemption) from the Healthcare Products Regulatory Agency before they can be released onto the market. 14/03/03
|
|
Background
Producing a new drug is an expensive and time-consuming process that is subject to extensive regulation. 27/08/02
|
|
|
|
Features
An ACE inhibitor that widens blood vessels and helps to relieve high blood pressure. 22/09/04
|
|
Features
Small-molecule drug used to treat male erectile dysfunction. 22/09/04
|
|
|
|
Features
Small-molecule drug used to treat chronic myeloid leukaemia. 19/04/04
|
|
Features
An RNA molecule that can inhibit the growth of new blood vessels around tumours. 19/04/04
|
|
|
|
Features
A therapeutic antibody used to treat advanced breast cancer. 04/02/04
|
|
Background
The boundaries between medicines and other products are becoming increasingly blurred, presenting new challenges to regulators. 14/03/03
|
|
|
|
Background
An independent research institute responsible for standardising and controlling biological substances used in medicine in the UK. 14/03/03
|
|
Technology centre
Large collections of chemical compounds that are screened to identify potential new drugs. 08/01/03
|
|
|
|
Background
Using structural information about drug targets or their natural ligands as a basis for the design of effective drugs. 27/08/02
|
|
Printable version
Send to a friend